Meta-analysis comparing efficacy of antibiotics versus oral contraceptives in acne vulgaris

被引:54
作者
Baughn, Eubee [1 ]
Petersen, Tyler Daniel [2 ]
Kimball, Alexandra Boer [1 ,3 ]
机构
[1] Harvard Univ, Sch Med, Boston, MA 02114 USA
[2] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Lebanon, NH USA
[3] Massachusetts Gen Hosp, Dept Dermatol, Boston, MA 02114 USA
关键词
acne vulgaris; birth control; meta-analysis; oral antibiotics; oral contraceptive; tetracyclines; 20; MU-G; DOUBLE-BLIND; ETHINYL ESTRADIOL; PROPIONIBACTERIUM-ACNES; TOPICAL CLINDAMYCIN; CYPROTERONE-ACETATE; CONTROLLED-TRIAL; MODERATE ACNE; PLACEBO; SAFETY;
D O I
10.1016/j.jaad.2014.03.051
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100227 [皮肤病学];
摘要
Background: Both antibiotics and oral contraceptive pills (OCPs) have been found to be effective in managing acne vulgaris. Despite widespread use, few direct comparisons of efficacy between the 2 modalities have been published. Objective: We compared the efficacy of antibiotics and OCPs in managing acne. Methods: A meta-analysis was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Cochrane collaboration guidelines. Results: A review of 226 publications yielded 32 randomized controlled trials that met our inclusion criteria. At 3 and 6 months, compared with placebo, both antibiotics and OCPs effected greater percent reduction in inflammatory, noninflammatory, and total lesions; the 2 modalities at each time point demonstrated statistical parity, except that antibiotics were superior to OCPs in percent reduction of total lesions at 3 months (weighted mean inflammatory lesion reduction: 3-month course of oral antibiotic treatment = 53.2%, 3-month course of OCPs = 35.6%, 3-month course of placebo treatment = 26.4%, 6-month course of oral antibiotic treatment = 57.9%, 6-month course of OCPs = 61.9%, 6-month course of placebo treatment = 34.2%; weighted mean noninflammatory lesion reduction: 3-month course of oral antibiotic treatment = 41.9%, 3-month course of OCPs = 32.6%, 3-month course of placebo treatment = 17.1%, 6-month course of oral antibiotic treatment = 56.4%, 6-month course of OCPs = 49.1%, 6-month course of placebo treatment = 23.4%; weighted mean total lesion reduction: 3-month course of oral antibiotic treatment = 48.0%, 3-month course of OCPs = 37.3%, 3-month course of placebo treatment = 24.5%, 6-month course of oral antibiotic treatment = 52.8%, 6-month course of OCPs = 55.0%, 6-month course of placebo treatment = 28.6%). Limitations: Investigative treatment heterogeneity and publication bias are limitations. Conclusions: Although antibiotics may be superior at 3 months, OCPs are equivalent to antibiotics at 6 months in reducing acne lesions and, thus, may be a better first-line alternative to systemic antibiotics for long-term acne management in women.
引用
收藏
页码:450 / 459
页数:10
相关论文
共 57 条
[1]
Ansarin H, 2008, J DRUGS DERMATOL, V7, P737
[2]
Arowojolu AO, 2012, COCHRANE DB SYST REV, V7
[3]
Bayer Schering Pharma, 2011, GA YAZ ACNE CHIN PHA
[4]
Physiologic and psychologic symptoms associated with use of injectable contraception and 20 μg oral contraceptive pills [J].
Berenson, Abbey B. ;
Odom, Susan D. ;
Breitkopf, Carmen Radecki ;
Rahman, Mahbubur .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 199 (04) :351.e1-351.e12
[5]
Propionibacterium acnes: an update on its role in the pathogenesis of acne [J].
Beylot, C. ;
Auffret, N. ;
Poli, F. ;
Claudel, J. -P. ;
Leccia, M. -T. ;
Del Giudice, P. ;
Dreno, B. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (03) :271-278
[6]
Bossuyt L, 2003, EUR J DERMATOL, V13, P130
[7]
Burkhart CN., 2012, FITZPATRICKS DERMATO, P2571
[8]
The association of serum androsterone glucuronide with inflammatory lesions in women with adult acne [J].
Carmina, E ;
Godwin, AJ ;
Stanczyk, FZ ;
Lippman, JS ;
Lobo, RA .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2002, 25 (09) :765-768
[9]
Is combined oral and topical therapy better than oral therapy alone in patients with moderate to moderately severe acne vulgaris? A comparison of the efficacy and safety of lymecycline plus adapalene gel 0.1%, versus lymecycline plus gel vehicle [J].
Cunliffe, WJ ;
Meynadier, J ;
Alirezai, M ;
George, SA ;
Coutts, I ;
Roseeuw, DI ;
Hachem, JP ;
Briantais, P ;
Sidou, F ;
Soto, P .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2003, 49 (03) :S218-S226
[10]
Cunliffe WJ, 1998, EUR J DERMATOL, V8, P161